NDC 68001-480
Irinotecan hydrochloide
Irinotecan Hydrochloide
Irinotecan hydrochloide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Irinotecan Hydrochloride.
| Product ID | 68001-480_47f7ef14-1f7a-e924-3fc5-a692f7199967 |
| NDC | 68001-480 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Irinotecan hydrochloide |
| Generic Name | Irinotecan Hydrochloide |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-12-14 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212993 |
| Labeler Name | BluePoint Laboratories |
| Substance Name | IRINOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |